Ex vivo T‐cell depletion vs post‐transplant cyclophosphamide, sirolimus, and mycophenolate mofetil as graft‐vs‐host disease prophylaxis for allogeneic hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Ex vivo T‐cell depletion vs post‐transplant cyclophosphamide, sirolimus, and mycophenolate mofetil as graft‐vs‐host disease prophylaxis for allogeneic hematopoietic stem cell transplantation

Published:2020-10-18 Issue:1 Volume:106 Page:114-125
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur. J. Haematol.

Author:

Montoro Juan¹²^ORCID,Roldán Elisa³,Piñana José Luis¹²,Barba Pere³^ORCID,Chorão Pedro¹,Quintero Abdiel¹,Hernani Rafael⁴,Ortí Guillermo³,Lorenzo José Ignacio¹,Balaguer‐Roselló Aitana¹,Salamero Olga³,Fox Laura³,Solves Pilar¹^ORCID,Gómez Inés¹,Guerreiro Manuel¹,Hernández Boluda Juan Carlos⁴⁵,Sanz Guillermo⁴⁵,Solano Carlos⁴⁵,Sanz Miguel Ángel¹⁵,Valcárcel David³,Sanz Jaime¹²

Affiliation:

1. Department of Hematology Hospital Universitario y Politécnico La Fe Valencia Spain

2. CIBERONC Instituto Carlos III Madrid Spain

3. Department of Hematology Vall d’Hebrón Institue of Oncology (VHIO) Hospital Universitario Vall d’Hebrón Universitat Autónoma de Barcelona Barcelona Spain

4. Department of Hematology Hospital Clínico Universitario Valencia Spain

5. Department of Medicine University of Valencia Valencia Spain

Publisher

Wiley

Subject

Hematology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ejh.13529

Reference38 articles.

1. Ex Vivo T Cell–Depleted versus Unmodified Allografts in Patients with Acute Myeloid Leukemia in First Complete Remission

2. Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation

3. Posttransplant cyclophosphamide vs cyclosporin A and methotrexate as GVHD prophylaxis in matched sibling transplantation

4. Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT

5. Graft-versus-Host Disease Prophylaxis in Unrelated Peripheral Blood Stem Cell Transplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PTCY and Tacrolimus for GVHD Prevention for Older Adults Undergoing HLA-Matched Sibling and Unrelated Donor AlloHCT;Transplantation and Cellular Therapy;2022-08

2. The Addition of Sirolimus to GVHD Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation: A Meta-Analysis of Efficacy and Safety;Frontiers in Oncology;2021-09-09